Leukaemia: Multiple origins of relapse
Nature Reviews Cancer 17, 453 (2017).
doi:10.1038/nrc.2017.67
Author: Ulrike Harjes
The origin of relapse in acute myeloid leukaemia (AML) is thought to be due to drug-promoted mutagenesis or to the selection of drug-resistant cells. Shlush et al. provide evidence for the latter and propose at least two distinct patterns of relapse in AML. In
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Ulrike Harjes Tags: Research Highlight Source Type: research